SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.19 CNY | +1.36% |
|
+3.02% | -23.53% |
| Sales 2021 | 347M 47.93M | Sales 2022 | 300M 41.4M | Capitalization | 6.32B 873M |
|---|---|---|---|---|---|
| Net income 2021 | 53M 7.31M | Net income 2022 | 122M 16.84M | EV / Sales 2021 | 28.2 x |
| Net cash position 2021 | 60.97M 8.41M | Net cash position 2022 | 235M 32.38M | EV / Sales 2022 | 20.3 x |
| P/E ratio 2021 |
191
x | P/E ratio 2022 |
51.7
x | Employees | 491 |
| Yield 2021 * |
-
| Yield 2022 |
0.58% | Free-Float | 42.29% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.00% | ||
| 1 week | +1.64% | ||
| Current month | -13.40% | ||
| 1 month | -15.83% | ||
| 3 months | -10.02% | ||
| 6 months | -25.60% | ||
| Current year | -24.56% |
1 week
7.52
8.15
1 month
7.379.62
Current year
6.0010.78
1 year
6.0011.87
3 years
6.0017.93
5 years
6.0054.03
10 years
4.2754.03
| Managers | Title | Age | Since |
|---|---|---|---|
Ben Yi Han
CEO | Chief Executive Officer | 59 | 23-07-31 |
Hua Ji
CHM | Chairman | 47 | 08-12-31 |
Qun Lin
DFI | Director of Finance/CFO | 55 | 20-12-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tian Min Liu
BRD | Director/Board Member | 63 | 21-05-24 |
Hai Ming Zhang
CHM | Chairman | 63 | - |
Yu Sheng Zhou
BRD | Director/Board Member | 69 | 17-12-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 8.19 | +1.36% | 3 170 400 |
| 24-04-24 | 8.08 | +1.00% | 3,577,100 |
| 24-04-23 | 8 | +2.70% | 4,670,800 |
| 24-04-22 | 7.79 | +1.56% | 4,533,700 |
| 24-04-19 | 7.67 | -1.79% | 3,732,900 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes
SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. is principally engaged in the research & development, production and sales of veterinary biological products. The Companyâs products mainly include escherichia coli (K88 and K99) gene modified vaccines for piglets, inactivated; porcine reproductive and respiratory syndrome vaccines, live and swine infectious atrophic rhinitis vaccines, inactivated; newcastle disease mild vaccines, living; newcastle disease, infectious bronchitis, egg drop syndromeâ76 vaccines, inactivated and infectious bronchitis vaccines, living, among others. The Company distributes its products mainly in China.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -24.56% | 734M | |
| -12.01% | 6.56B | |
| +16.00% | 3.43B | |
| -3.48% | 3.22B | |
| -2.20% | 1.46B | |
| -14.67% | 1.38B | |
| -3.61% | 1.26B | |
| -27.57% | 1.21B | |
| -12.86% | 1.14B | |
| -2.99% | 1.02B |
- Stock Market
- Equities
- 603718 Stock
